These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 27302378)
1. Preserved hemostatic status in patients with non-alcoholic fatty liver disease. Potze W; Siddiqui MS; Boyett SL; Adelmeijer J; Daita K; Sanyal AJ; Lisman T J Hepatol; 2016 Nov; 65(5):980-987. PubMed ID: 27302378 [TBL] [Abstract][Full Text] [Related]
2. Procoagulant imbalance in patients with non-alcoholic fatty liver disease. Tripodi A; Fracanzani AL; Primignani M; Chantarangkul V; Clerici M; Mannucci PM; Peyvandi F; Bertelli C; Valenti L; Fargion S J Hepatol; 2014 Jul; 61(1):148-54. PubMed ID: 24657400 [TBL] [Abstract][Full Text] [Related]
3. Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease. Eriksen PL; Thomsen KL; Sørensen M; Vilstrup H; Hvas AM Thromb Res; 2022 May; 213():9-15. PubMed ID: 35256195 [TBL] [Abstract][Full Text] [Related]
4. Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis. Bos S; van den Boom B; Kamphuisen PW; Adelmeijer J; Blokzijl H; Schreuder T; Lisman T Thromb Haemost; 2019 Feb; 119(2):246-253. PubMed ID: 30609442 [TBL] [Abstract][Full Text] [Related]
5. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. Zanetto A; Campello E; Bulato C; Gavasso S; Saggiorato G; Shalaby S; Burra P; Angeli P; Senzolo M; Simioni P JHEP Rep; 2022 Jul; 4(7):100493. PubMed ID: 35647501 [TBL] [Abstract][Full Text] [Related]
6. Clinical Features of Non-Alcoholic Fatty Liver Disease in the Non-Lean Population. Li MR; Li JZ; Li JY; Wang CC; Yuan RK; Ye LH; Liu YY; Liang XJ; Zhang HC; Liu ZQ; Zeng DY; Zhang XD; Wang DH; Li JQ; Li TY; Yang L; Cao Y; Pan Y; Lin XG; Pan CQ; Dai EH; Dong ZY Obes Facts; 2023; 16(5):427-434. PubMed ID: 37231905 [TBL] [Abstract][Full Text] [Related]
7. Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease. Lisman T; Arefaine B; Adelmeijer J; Zamalloa A; Corcoran E; Smith JG; Bernal W; Patel VC J Thromb Haemost; 2021 Jan; 19(1):85-95. PubMed ID: 33006808 [TBL] [Abstract][Full Text] [Related]
8. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682 [TBL] [Abstract][Full Text] [Related]
9. THE INFLUENCE OF HYPERCHOLESTEROLEMIA AND CONCOMITANT STATIN THERAPY ON THE STATE OF PLATELET-PLASMA HEMOSTASIS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND NON-ALCOHOLIC FATTY LIVER DISEASE. Netyazhenko V; Bazhenova N Georgian Med News; 2021 Sep; (318):75-81. PubMed ID: 34628383 [TBL] [Abstract][Full Text] [Related]
10. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels. Akyuz U; Yesil A; Yilmaz Y Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258 [TBL] [Abstract][Full Text] [Related]
12. The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients. Vespasiani-Gentilucci U; Gallo P; Porcari A; Carotti S; Galati G; Piccioni L; De Vincentis A; Dell'Unto C; Vorini F; Morini S; Riva E; Picardi A Scand J Gastroenterol; 2016 Aug; 51(8):967-73. PubMed ID: 27150500 [TBL] [Abstract][Full Text] [Related]
14. Hemostatic changes in patients with liver cirrhosis. Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296 [TBL] [Abstract][Full Text] [Related]
15. Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution. Tana C; Tana M; Rossi S; Silingardi M; Schiavone C J Ultrasound; 2016 Sep; 19(3):183-9. PubMed ID: 27635163 [TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis. Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795 [TBL] [Abstract][Full Text] [Related]
17. Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases. Weinberg EM; Trinh HN; Firpi RJ; Bhamidimarri KR; Klein S; Durlam J; Watkins S; Reddy KR; Weiss M; Zink RC; Lok AS Clin Gastroenterol Hepatol; 2021 May; 19(5):996-1008.e6. PubMed ID: 32629123 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Qureshi K; Abrams GA Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683 [TBL] [Abstract][Full Text] [Related]